APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Therapeutic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Radiopharmaceuticals for Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Therapeutic Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Therapeutic Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Therapeutic Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Therapeutic Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiopharmaceuticals for Therapeutic include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Radiopharmaceuticals for Therapeutic market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiopharmaceuticals for Therapeutic and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceuticals for Therapeutic revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Radiopharmaceuticals for Therapeutic market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceuticals for Therapeutic Segment by Company

Novartis

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Dongcheng

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Radiopharmaceuticals for Therapeutic Segment by Type

Radium-223

Lutetium-177

Iodine-131

Other

Radiopharmaceuticals for Therapeutic Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Radiopharmaceuticals for Therapeutic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Radiopharmaceuticals for Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceuticals for Therapeutic industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals for Therapeutic companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceuticals for Therapeuticrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Radium-223 Table 3. Key Players of Lutetium-177 Table 4. Key Players of Iodine-131 Table 3. Key Players of Other Table 4. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Lymphoma Table 6. Key Players of Thyroid Table 7. Key Players of Bone Metastasis Table 8. Key Players of Other Table 9. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Radiopharmaceuticals for Therapeutic Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2021-2026) Table 12. Global Radiopharmaceuticals for Therapeutic Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2027-2032) Table 14. Radiopharmaceuticals for Therapeutic Industry Trends Table 15. Radiopharmaceuticals for Therapeutic Industry Drivers Table 16. Radiopharmaceuticals for Therapeutic Industry Opportunities and Challenges Table 17. Radiopharmaceuticals for Therapeutic Industry Restraints Table 18. Global Radiopharmaceuticals for Therapeutic Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Company (2021-2026) Table 20. Global Radiopharmaceuticals for Therapeutic Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Radiopharmaceuticals for Therapeutic Key Company Head Office and Area Served Table 22. Global Radiopharmaceuticals for Therapeutic Company, Product Type & Application Table 23. Global Radiopharmaceuticals for Therapeutic Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Radiopharmaceuticals for Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Radiopharmaceuticals for Therapeutic Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2021-2026) Table 30. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2027-2032) Table 31. Global Radiopharmaceuticals for Therapeutic Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2021-2026) Table 35. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Radiopharmaceuticals for Therapeutic Product Portfolio Table 40. Novartis Recent Development Table 41. Bayer Company Information Table 42. Bayer Business Overview Table 43. Bayer Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bayer Radiopharmaceuticals for Therapeutic Product Portfolio Table 45. Bayer Recent Development Table 46. Q BioMed Company Information Table 47. Q BioMed Business Overview Table 48. Q BioMed Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Q BioMed Radiopharmaceuticals for Therapeutic Product Portfolio Table 50. Q BioMed Recent Development Table 51. Mundipharma Company Information Table 52. Mundipharma Business Overview Table 53. Mundipharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Mundipharma Radiopharmaceuticals for Therapeutic Product Portfolio Table 55. Mundipharma Recent Development Table 56. Lantheus Company Information Table 57. Lantheus Business Overview Table 58. Lantheus Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Lantheus Radiopharmaceuticals for Therapeutic Product Portfolio Table 60. Lantheus Recent Development Table 61. Jubilant Radiopharma Company Information Table 62. Jubilant Radiopharma Business Overview Table 63. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product Portfolio Table 65. Jubilant Radiopharma Recent Development Table 66. International Isotopes Company Information Table 67. International Isotopes Business Overview Table 68. International Isotopes Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. International Isotopes Radiopharmaceuticals for Therapeutic Product Portfolio Table 70. International Isotopes Recent Development Table 71. Dongcheng Company Information Table 72. Dongcheng Business Overview Table 73. Dongcheng Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Dongcheng Radiopharmaceuticals for Therapeutic Product Portfolio Table 75. Dongcheng Recent Development Table 76. Curium Pharmaceuticals Company Information Table 77. Curium Pharmaceuticals Business Overview Table 78. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Portfolio Table 80. Curium Pharmaceuticals Recent Development Table 81. China Isotope & Radiation Company Information Table 82. China Isotope & Radiation Business Overview Table 83. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Portfolio Table 85. China Isotope & Radiation Recent Development Table 86. Aurobindo Pharma Company Information Table 87. Aurobindo Pharma Business Overview Table 88. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product Portfolio Table 90. Aurobindo Pharma Recent Development Table 91. North America Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 92. North America Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 93. North America Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 94. North America Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 95. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026) Table 97. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032) Table 98. Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 99. Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 100. Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 101. Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 102. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026) Table 104. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032) Table 105. China Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 106. China Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 107. China Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 108. China Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 110. Asia Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 111. Asia Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 112. Asia Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026) Table 115. Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032) Table 116. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026) Table 122. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Radiopharmaceuticals for Therapeutic Product Image Figure 2. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Radiopharmaceuticals for Therapeutic Market Share by Type: 2025 VS 2032 Figure 4. Radium-223 Image Figure 5. Lutetium-177 Image Figure 6. Iodine-131 Image Figure 7. Other Image Figure 8. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Radiopharmaceuticals for Therapeutic Market Share by Application: 2025 VS 2032 Figure 10. Lymphoma Image Figure 11. Thyroid Image Figure 12. Bone Metastasis Image Figure 13. Other Image Figure 14. Global Radiopharmaceuticals for Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 16. Global Radiopharmaceuticals for Therapeutic Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Radiopharmaceuticals for Therapeutic Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Radiopharmaceuticals for Therapeutic Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2021-2032) Figure 23. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2021-2032) Figure 25. North America Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 26. North America Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032) Figure 27. North America Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032) Figure 28. North America Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032) Figure 29. United States Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 30. Canada Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 32. Europe Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 33. Europe Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032) Figure 34. Europe Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032) Figure 35. Europe Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032) Figure 36. Germany Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 37. France Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 39. Italy Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 40. Russia Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 42. China Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 43. China Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032) Figure 44. China Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032) Figure 45. Asia Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 46. Asia Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032) Figure 47. Asia Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032) Figure 48. Asia Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032) Figure 49. Japan Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 53. India Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 54. Australia Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032) Figure 59. Brazil Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 64. UAE Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 66. Chile Radiopharmaceuticals for Therapeutic Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Dongcheng
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Radium-223
  5. 1.2.3 Lutetium-177
  6. 1.2.4 Iodine-131
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Lymphoma
  11. 1.3.3 Thyroid
  12. 1.3.4 Bone Metastasis
  13. 1.3.5 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Radiopharmaceuticals for Therapeutic Growth Trends by Region
  16. 1.5.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Radiopharmaceuticals for Therapeutic Market Size by Region (2021-2026)
  18. 1.5.3 Radiopharmaceuticals for Therapeutic Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Radiopharmaceuticals for Therapeutic Market Dynamics
  1. 2.1 Radiopharmaceuticals for Therapeutic Industry Trends
  2. 2.2 Radiopharmaceuticals for Therapeutic Industry Drivers
  3. 2.3 Radiopharmaceuticals for Therapeutic Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals for Therapeutic Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Radiopharmaceuticals for Therapeutic Revenue by Company (2021-2026)
  2. 3.2 Global Radiopharmaceuticals for Therapeutic Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Radiopharmaceuticals for Therapeutic Key Company Head office and Area Served
  4. 3.4 Global Radiopharmaceuticals for Therapeutic Company, Product Type & Application
  5. 3.5 Global Radiopharmaceuticals for Therapeutic Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Radiopharmaceuticals for Therapeutic Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Radiopharmaceuticals for Therapeutic Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Radiopharmaceuticals for Therapeutic Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals for Therapeutic Market by Type
  1. 4.1 Global Radiopharmaceuticals for Therapeutic Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2032)
  3. 4.3 Global Radiopharmaceuticals for Therapeutic Market Size Share by Type (2021-2032)
5 Radiopharmaceuticals for Therapeutic Market by Application
  1. 5.1 Global Radiopharmaceuticals for Therapeutic Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2032)
  3. 5.3 Global Radiopharmaceuticals for Therapeutic Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Radiopharmaceuticals for Therapeutic Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bayer Radiopharmaceuticals for Therapeutic Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Q BioMed
  14. 6.3.1 Q BioMed Company Information
  15. 6.3.2 Q BioMed Business Overview
  16. 6.3.3 Q BioMed Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Q BioMed Radiopharmaceuticals for Therapeutic Product Portfolio
  18. 6.3.5 Q BioMed Recent Developments
  19. 6.4 Mundipharma
  20. 6.4.1 Mundipharma Company Information
  21. 6.4.2 Mundipharma Business Overview
  22. 6.4.3 Mundipharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mundipharma Radiopharmaceuticals for Therapeutic Product Portfolio
  24. 6.4.5 Mundipharma Recent Developments
  25. 6.5 Lantheus
  26. 6.5.1 Lantheus Company Information
  27. 6.5.2 Lantheus Business Overview
  28. 6.5.3 Lantheus Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lantheus Radiopharmaceuticals for Therapeutic Product Portfolio
  30. 6.5.5 Lantheus Recent Developments
  31. 6.6 Jubilant Radiopharma
  32. 6.6.1 Jubilant Radiopharma Company Information
  33. 6.6.2 Jubilant Radiopharma Business Overview
  34. 6.6.3 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product Portfolio
  36. 6.6.5 Jubilant Radiopharma Recent Developments
  37. 6.7 International Isotopes
  38. 6.7.1 International Isotopes Company Information
  39. 6.7.2 International Isotopes Business Overview
  40. 6.7.3 International Isotopes Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 International Isotopes Radiopharmaceuticals for Therapeutic Product Portfolio
  42. 6.7.5 International Isotopes Recent Developments
  43. 6.8 Dongcheng
  44. 6.8.1 Dongcheng Company Information
  45. 6.8.2 Dongcheng Business Overview
  46. 6.8.3 Dongcheng Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Dongcheng Radiopharmaceuticals for Therapeutic Product Portfolio
  48. 6.8.5 Dongcheng Recent Developments
  49. 6.9 Curium Pharmaceuticals
  50. 6.9.1 Curium Pharmaceuticals Company Information
  51. 6.9.2 Curium Pharmaceuticals Business Overview
  52. 6.9.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Portfolio
  54. 6.9.5 Curium Pharmaceuticals Recent Developments
  55. 6.10 China Isotope & Radiation
  56. 6.10.1 China Isotope & Radiation Company Information
  57. 6.10.2 China Isotope & Radiation Business Overview
  58. 6.10.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Portfolio
  60. 6.10.5 China Isotope & Radiation Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
7 North America
  1. 7.1 North America Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
  2. 7.2 North America Radiopharmaceuticals for Therapeutic Market Size by Type
  3. 7.2.1 North America Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026)
  4. 7.2.2 North America Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032)
  5. 7.2.3 North America Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032)
  6. 7.3 North America Radiopharmaceuticals for Therapeutic Market Size by Application
  7. 7.3.1 North America Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026)
  8. 7.3.2 North America Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032)
  9. 7.3.3 North America Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032)
  10. 7.4 North America Radiopharmaceuticals for Therapeutic Market Size by Country
  11. 7.4.1 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
  13. 7.4.3 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032)
  14. 7.4.4 North America Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
  2. 8.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Type
  3. 8.2.1 Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026)
  4. 8.2.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032)
  5. 8.2.3 Europe Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032)
  6. 8.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Application
  7. 8.3.1 Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026)
  8. 8.3.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032)
  9. 8.3.3 Europe Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032)
  10. 8.4 Europe Radiopharmaceuticals for Therapeutic Market Size by Country
  11. 8.4.1 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
  13. 8.4.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032)
  14. 8.4.4 Europe Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
  2. 9.2 China Radiopharmaceuticals for Therapeutic Market Size by Type
  3. 9.2.1 China Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026)
  4. 9.2.2 China Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032)
  5. 9.2.3 China Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032)
  6. 9.3 China Radiopharmaceuticals for Therapeutic Market Size by Application
  7. 9.3.1 China Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026)
  8. 9.3.2 China Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032)
  9. 9.3.3 China Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
  2. 10.2 Asia Radiopharmaceuticals for Therapeutic Market Size by Type
  3. 10.2.1 Asia Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026)
  4. 10.2.2 Asia Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032)
  5. 10.2.3 Asia Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032)
  6. 10.3 Asia Radiopharmaceuticals for Therapeutic Market Size by Application
  7. 10.3.1 Asia Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026)
  8. 10.3.2 Asia Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032)
  9. 10.3.3 Asia Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032)
  10. 10.4 Asia Radiopharmaceuticals for Therapeutic Market Size by Country
  11. 10.4.1 Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
  13. 10.4.3 Asia Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032)
  14. 10.4.4 Asia Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst